144 related articles for article (PubMed ID: 4621009)
1. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
Versteeg DH; van Ree JM; Provoost AP; de Jong W
Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
[No Abstract] [Full Text] [Related]
2. Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment.
Oke A; Keller R; Adams RN
Brain Res; 1978 Jun; 148(1):245-50. PubMed ID: 656929
[No Abstract] [Full Text] [Related]
3. [Morphological restructurings in the brain due to a decrease in the catecholamine level].
Otellin VA; Kucherenko RP; Gilerovich EG; Usova IP; Fedosikhina LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):978-81. PubMed ID: 6089476
[TBL] [Abstract][Full Text] [Related]
4. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
Kaplanski J; Nyakas C; van Delft AM; Smelik PG
Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
[No Abstract] [Full Text] [Related]
5. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
Fobes JL; Olds ME
Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine, phenytoin and phenobarbital do not influence brain catecholamine uptake, in vivo, in male rats.
Quattrone A; Annunziato L; Aguglia U; Preziosi P
Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):180-5. PubMed ID: 7305556
[TBL] [Abstract][Full Text] [Related]
7. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
Oke A; Freeman R; Adams RN
Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
[No Abstract] [Full Text] [Related]
8. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
Jonsson G; Sachs C
Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
[TBL] [Abstract][Full Text] [Related]
9. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
Peters DA; Pappas BA; Taub H; Saari M
Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
[No Abstract] [Full Text] [Related]
10. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
Cooper BR; Cott JM; Breese GR
Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
[No Abstract] [Full Text] [Related]
11. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
Samanin R; Bernasconi S; Garattini S
Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
[TBL] [Abstract][Full Text] [Related]
12. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
Suenaga N; Yamada K; Fukuda T
Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
[No Abstract] [Full Text] [Related]
13. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
[TBL] [Abstract][Full Text] [Related]
14. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.
Mason ST; Corcoran ME
J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457
[TBL] [Abstract][Full Text] [Related]
15. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
Liuzzi A; Foppen FH; Angeletti PU
Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
[No Abstract] [Full Text] [Related]
16. Neonatal methylmercury poisoning in the rat: effects on development of central catecholamine neurotransmitter systems.
Bartolome J; Trepanier P; Chait EA; Seidler FJ; Deskin R; Slotkin TA
Toxicol Appl Pharmacol; 1982 Aug; 65(1):92-9. PubMed ID: 6128806
[No Abstract] [Full Text] [Related]
17. Effect of etoperidone on the depletion of brain 5-hydroxytryptamine and catecholamines induced respectively by p-chloromethamphetamine and 6-hydroxydopamine in rats.
Carruba MO; Parenti M; Ricciardi S; Picotti GB; Mantegazza P
Pharmacol Res Commun; 1979 Feb; 11(2):169-77. PubMed ID: 155821
[No Abstract] [Full Text] [Related]
18. Differential effects of alpha-methyl-p-tyrosine and 6-hydroxydopamine on pentylenetetrazol seizures in mice.
Abed WT
Pharmacol Biochem Behav; 1986 Nov; 25(5):949-52. PubMed ID: 3097680
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
Widerlöv E; Lewander T
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
